The Chemical Backbone: Shikimic Acid as a Pharmaceutical Intermediate
Shikimic acid, bearing the CAS number 138-59-0, stands as a pivotal molecule in the pharmaceutical industry, primarily recognized as a key precursor in the synthesis of oseltamivir (Tamiflu). This crucial antiviral agent's production relies heavily on the availability of high-quality shikimic acid. NINGBO INNO PHARMCHEM CO.,LTD. ensures this vital supply chain component is readily accessible for global pharmaceutical needs.
The molecule's story begins with its natural occurrence in plants such as star anise. Understanding the complexities of the shikimic acid biosynthesis pathway in plants and microorganisms is fundamental to its industrial production. This pathway is essential for creating aromatic amino acids and many other vital compounds. Advancements in biotechnology have led to efficient fermentation processes, complementing traditional extraction methods, thereby securing the supply of this vital shikimic acid pharmaceutical intermediate.
The significance of shikimic acid extends beyond its role in antiviral drug manufacturing. Emerging research highlights a wide array of its shikimic acid biological activities. Its antioxidant and anti-inflammatory properties are particularly promising, offering potential therapeutic benefits for conditions associated with oxidative stress and inflammation. Scientists are actively investigating these attributes, seeking to harness shikimic acid's potential for novel drug development.
Furthermore, the discovery of potent shikimic acid antibacterial properties is expanding its therapeutic horizon. In an era where antibiotic resistance is a major global health challenge, the identification of new antibacterial agents is critical. Shikimic acid's demonstrated efficacy against various bacterial strains marks it as a compound of considerable interest for developing new treatments. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying researchers and manufacturers with this essential compound, facilitating advancements in drug synthesis and the exploration of its diverse biological applications.
Perspectives & Insights
Future Origin 2025
“Shikimic acid, bearing the CAS number 138-59-0, stands as a pivotal molecule in the pharmaceutical industry, primarily recognized as a key precursor in the synthesis of oseltamivir (Tamiflu).”
Core Analyst 01
“This crucial antiviral agent's production relies heavily on the availability of high-quality shikimic acid.”
Silicon Seeker One
“ensures this vital supply chain component is readily accessible for global pharmaceutical needs.”